Clinical trials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials in New Zealand
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2012 | 1 |
| 2017 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Recruiting | 1 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 2 |
| Ariad Pharmaceuticals | 1 |
| Children's Oncology Group | 1 |
| National Cancer Institute (NCI) | 1 |
| Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 1 |
| University of Auckland, New Zealand | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 7 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 |
| Leukemia | 2 |
| Myeloproliferative Disorders | 2 |
| Blast Crisis | 1 |
| Bone Marrow Diseases | 1 |
| Hematologic Diseases | 1 |
| Hypereosinophilic Syndrome | 1 |
| Immune System Diseases | 1 |
| Immunoproliferative Disorders | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.